Lobbying Activity Report


Organization: Innovative Medicines Canada (Medicaments novateurs Canada)
Associated registration: 1393-1774-10
Lobbying Activity date: 2020-07-14
Arranged a meeting: No
Posted date: 2020-07-30

In-house lobbyists who participated in the lobbying activity: Anne Babineau
Senior Public Office Holders who were lobbied in this activity: Norm Letnick, Member of Legislative Assembly
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Engage with the BC government to advocate for greater access to innovative medicines and vaccines for British Columbians, supportive policies to attract research and development investment, and greater collaboration to build a stronger life sciences sector and a more sustainable health system.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
Senior officer who filed this Lobbying Activity Report: Pamela Fralick
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: